Société Algérienne De Formation Et Recherche En Oncologie
Clinical trials sponsored by Société Algérienne De Formation Et Recherche En Oncologie, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Biosimilar for breast cancer tracked in real-world study Results expected Jan 2027 (estimated)
-
Biosimilar for breast cancer tracked in real-world study
Knowledge-focused Recruiting nowThis observational study is following 1,000 people with HER2-positive breast cancer who are receiving a pertuzumab biosimilar as part of their routine care. The goal is to see how doctors are using the drug and how well it works in both neoadjuvant (before surgery) and first-line…
Sponsor: Société Algérienne de Formation et Recherche en Oncologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Algerian prostate cancer study seeks 2,000 men
Knowledge-focused Recruiting nowThis study aims to describe the characteristics of prostate cancer in Algeria, including patient demographics, symptoms, diagnosis methods, and treatments. Researchers will collect data from 2,000 men aged 19 and older with confirmed prostate cancer. The goal is to better underst…
Sponsor: Société Algérienne de Formation et Recherche en Oncologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Algerian gastric cancer study aims to map diagnosis and care
Knowledge-focused Recruiting nowThis observational study will follow 1,000 adults in Algeria who have been diagnosed with gastric cancer. Researchers will collect information on patient demographics, risk factors, symptoms, how the cancer is diagnosed, and what treatments are used. The goal is to better underst…
Sponsor: Société Algérienne de Formation et Recherche en Oncologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC